Advertisement

Risk factors for cardiovascular mortality in patients with colorectal cancer: a population-based study

  • Apostolos GaitanidisEmail author
  • Michail Spathakis
  • Christos Tsalikidis
  • Michail Alevizakos
  • Alexandra Tsaroucha
  • Michail Pitiakoudis
Original Article
  • 43 Downloads

Abstract

Background

Patients with colorectal cancer are at increased risk of cardiovascular mortality compared to the general population. The purpose of this study is to identify risk factors of cardiovascular mortality in patients with colorectal cancer.

Methods

A retrospective review of the Surveillance Epidemiology and End Results (SEER) database was performed between 2010 and 2014. Standardized Mortality Ratios (SMRs) for cardiovascular mortality were calculated by comparing the number of expected deaths in the United States according to the National Center for Health Statistics (ICD-10 codes I00-I99) to the number of observed deaths in the database. Logistic regression was used to identify independent risk factors.

Results

Overall, 164,719 patients were identified (mean age at diagnosis 67 ± 13.9 years, 52.7% males, 47.3% females), of which 4854 (2.9%) died from cardiovascular disease. The majority of cardiovascular deaths occurred during the first year after diagnosis (2658, 54.8%). SMRs for cardiovascular mortality were 11.7 (95% CI 11.3–12) among all patients, 12.1 (95% CI 11.7–12.6) for male patients and 11.1 (95% CI 10.6–11.6) for female patients, with SMRs being higher for younger patients. Older age, male sex, African–American race, elevated CEA and not undergoing curative surgery were independent risk factors of cardiovascular mortality in patients with colorectal cancer.

Conclusion

Patients with colorectal cancer are associated with an increased risk of cardiovascular death, especially during the first year after diagnosis. Older age, male sex, African–American race, elevated CEA and not undergoing curative surgery are independent risk factors of cardiovascular death.

Keywords

Colorectal cancer Cardiovascular Mortality 

Notes

Acknowledgements

This study was supported by the General Secretariat for Research and Technology (GSRT) (Grant no. 837) and the Hellenic Foundation for Research and Innovation (HFRI).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

10147_2018_1382_MOESM1_ESM.docx (16 kb)
Supplementary material 1 (DOCX 16 KB)

References

  1. 1.
    GBD 2016 Causes of Death Collaborators G 2016 C of D (2017) Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1151–1210.  https://doi.org/10.1016/S0140-6736(17)32152-9 CrossRefGoogle Scholar
  2. 2.
    Kuipers EJ, Grady WM, Lieberman D et al (2015) Colorectal cancer. Nat Rev Dis Prim 1:15065.  https://doi.org/10.1038/nrdp.2015.65 CrossRefGoogle Scholar
  3. 3.
    Hee YJ, Bang CS, Baik GH et al (2016) Association between ischemic heart disease and colorectal neoplasm: a systematic review and meta-analysis. Springerplus 5:1664.  https://doi.org/10.1186/s40064-016-3349-0 CrossRefPubMedCentralGoogle Scholar
  4. 4.
    Koene RJ, Prizment AE, Blaes A et al (2016) Shared risk factors in cardiovascular disease and cancer. Circulation 133:1104–1114.  https://doi.org/10.1161/CIRCULATIONAHA.115.020406 CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Chan AOO, Lam KF, Tong T et al (2006) Coexistence between colorectal cancer/adenoma and coronary artery disease: results from 1382 patients. Aliment Pharmacol Ther 24:535–539.  https://doi.org/10.1111/j.1365-2036.2006.02958.x CrossRefGoogle Scholar
  6. 6.
    Weaver KE, Foraker RE, Alfano CM et al (2013) Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv 7:253–261.  https://doi.org/10.1007/s11764-013-0267-9 CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Dekker JWT, Gooiker GA, Bastiaannet E et al (2014) Cause of death the first year after curative colorectal cancer surgery; a prolonged impact of the surgery in elderly colorectal cancer patients. Eur J Surg Oncol 40:1481–1487.  https://doi.org/10.1016/J.EJSO.2014.05.010 CrossRefGoogle Scholar
  8. 8.
    Aquina CT, Mohile SG, Tejani MA et al (2017) The impact of age on complications, survival and cause of death following colon cancer surgery. Br J Cancer 116:389–397.  https://doi.org/10.1038/bjc.2016.421 CrossRefPubMedCentralGoogle Scholar
  9. 9.
    van de Poll-Franse LV, Haak HR, Coebergh JWW et al (2012) Disease-specific mortality among stages I–III colorectal cancer patients with diabetes: a large population-based analysis. Diabetologia 55:2163–2172.  https://doi.org/10.1007/s00125-012-2555-8 CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Lewis A, Ituarte PH, Melstrom K (2017) Causes of death in long-term survivors of colorectal cancer. In: Society of Surgical Oncology annual cancer symposiumGoogle Scholar
  11. 11.
    Harrell FE, Lee KL, Califf RM et al Regression modelling strategies for improved prognostic prediction. Stat Med 3:143–152Google Scholar
  12. 12.
    Mármol I, Sánchez-de-Diego C, Pradilla Dieste A et al (2017) Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci.  https://doi.org/10.3390/ijms18010197 Google Scholar
  13. 13.
    Mercado C, Jaimes EA (2007) Cigarette smoking as a risk factor for atherosclerosis and renal disease: novel pathogenic insights. Curr Hypertens Rep 9:66–72CrossRefGoogle Scholar
  14. 14.
    Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87:840–844CrossRefGoogle Scholar
  15. 15.
    Al-Kindi SG, Oliveira GH (2016) Incidence and trends of cardiovascular mortality after common cancers in young adults: analysis of surveillance, epidemiology and end-results program. World J Cardiol 8:368–374.  https://doi.org/10.4330/wjc.v8.i6.368 CrossRefPubMedCentralGoogle Scholar
  16. 16.
    Zaorsky N, Churilla T, Egleston B et al (2016) Causes of death among cancer patients. Ann Oncol.  https://doi.org/10.1093/annonc/mdw604 PubMedCentralGoogle Scholar
  17. 17.
    Herrmann J, Lerman A, Sandhu NP et al (2014) Evaluation and management of patients with heart disease and cancer: cardio-oncology. Mayo Clin Proc 89:1287–1306.  https://doi.org/10.1016/j.mayocp.2014.05.013 CrossRefPubMedCentralGoogle Scholar
  18. 18.
    Kapelakis I, Toutouzas K, Drakopoulou M et al (2017) Bevacizumab increases the incidence of cardiovascular events in patients with metastatic breast or colorectal cancer. Hell J Cardiol 58:215–219.  https://doi.org/10.1016/J.HJC.2016.11.022 CrossRefGoogle Scholar
  19. 19.
    Benson AB, Venook AP, Bekaii-Saab T et al (2014) Colon cancer, version 3.2014. J Natl Compr Canc Netw 12:1028–1059CrossRefGoogle Scholar
  20. 20.
    Benson AB, Venook AP, Bekaii-Saab T et al (2015) Rectal cancer, version 2.2015. J Natl Compr Cancer Netw 13:719–728 (quiz 728) CrossRefGoogle Scholar
  21. 21.
    Kander MC, Cui Y, Liu Z (2017) Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases. J Cell Mol Med 21:1024–1032.  https://doi.org/10.1111/jcmm.13038 CrossRefGoogle Scholar
  22. 22.
    Benjamin EJ, Blaha MJ, Chiuve SE et al (2017) Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation 135:e146–e603.  https://doi.org/10.1161/CIR.0000000000000485 CrossRefPubMedCentralGoogle Scholar
  23. 23.
    Carnethon MR, Pu J, Howard G et al (2017) Cardiovascular health in African Americans: a scientific statement from the American Heart Association. Circulation.  https://doi.org/10.1161/CIR.0000000000000534 PubMedCentralGoogle Scholar
  24. 24.
    Thomas DS, Fourkala E-O, Apostolidou S et al (2015) Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples. Br J Cancer 113:268–274.  https://doi.org/10.1038/bjc.2015.202 CrossRefPubMedCentralGoogle Scholar
  25. 25.
    Vukobrat-Bijedic Z, Husic-Selimovic A, Sofic A et al (2013) Cancer antigens (CEA and CA 19–9) as markers of advanced stage of colorectal carcinoma. Med Arch (Sarajevo Bosnia Herzegovina) 67:397–401.  https://doi.org/10.5455/medarh.2013.67.397-401 Google Scholar
  26. 26.
    D’Agostino RB, Vasan RS, Pencina MJ et al (2008) General cardiovascular risk profile for use in primary care. Circulation 117:743–753.  https://doi.org/10.1161/CIRCULATIONAHA.107.699579 CrossRefGoogle Scholar
  27. 27.
    Fihn SD, Blankenship JC, Alexander KP et al (2014) 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease. Circulation 130:1749–1767.  https://doi.org/10.1161/CIR.0000000000000095 CrossRefGoogle Scholar

Copyright information

© Japan Society of Clinical Oncology 2019

Authors and Affiliations

  1. 1.Second Department of SurgeryUniversity General Hospital of Alexandroupoli, Democritus University of Thrace Medical SchoolAlexandroupoliGreece
  2. 2.Department of MedicineUniversity of Pittsburgh Medical Center, Department of MedicinePittsburghUSA

Personalised recommendations